Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95,490,450
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
12,740,024
-
Shares change
-
+1,251,465
-
Total reported value, excl. options
-
$233,652,737
-
Value change
-
+$24,305,612
-
Put/Call ratio
-
70%
-
Number of buys
-
35
-
Number of sells
-
28
-
Price
-
$18.34
Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q1 2019
As of 31 Mar 2019 Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) had 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 12,740,024 shares of stock of the company.
Largest 10 holders included FMR LLC, ARK Investment Management LLC, Capital World Investors, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., ARMISTICE CAPITAL, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Inc., CREDIT SUISSE AG/, and SPHERA FUNDS MANAGEMENT LTD..
This table shows 81 institutional shareholders of the security as of 31 Mar 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.